FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, and concerns a general health-improving agent in treating new growths. Substance of the invention covers avirulent bacteria suspension in a stable, irreversible L-form of strain No. 118-L3 with metabolic products in 1-2 % sodium chloride.
EFFECT: development of the agent improving general body resistance.
6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIGEN FOR ANTICANCER ANTIBODIES | 2006 |
|
RU2356578C2 |
| METHOD OF VACCINATION AGAINST DIPHTHERIA IN CHILDREN WITH SYSTEM CONJUNCTIVE TISSUE DISEASES | 1996 |
|
RU2127601C1 |
| POLYVALENT CORPUSCULAR ANTIGEN FOR PRODUCTION OF MEDICAL AND PREVENTIVE BIOLOGICAL PRODUCTS FOR BRUCELLOSIS | 2006 |
|
RU2330681C1 |
| COMBINED IMMUNOTHERAPEUTIC APPROACH TO CANCER TREATMENT | 2015 |
|
RU2716821C2 |
| METHOD FOR TREATING POSTOPERATIONAL PURULENT-INFLAMMATORY COMPLICATIONS INDUCED BY CROSS INFECTION | 2003 |
|
RU2246273C2 |
| METHOD OF ACUTE RESPIRATORY DISEASES PREVENTION DURING POSTVACCINAL PERIOD FOR CHILDREN SUFFERING FROM CHRONIC GLOMERULONEPHRITIS AND CHRONIC RENAL INSUFFICIENCY | 2005 |
|
RU2325182C2 |
| BRUCELLA ABORTUS UF-1 STRAIN FOR PREPARING BIOLOGICAL PREPARATIONS FOR DIAGNOSTICS AND SPECIFIC PREVENTION OF BRUCELLOSIS IN FARM ANIMALS | 2007 |
|
RU2425148C2 |
| METHOD FOR PREPARING ANTICANCER AGENT FOR TREATING SOLID TUMOURS | 2012 |
|
RU2521193C2 |
| LIVE VACCINE BASED ON ENTEROCOCCUS FAECIUM L3 PROBIOTIC STRAIN FOR PREVENTION OF INFECTION CAUSED BY STREPTOCOCCUS PNEUMONIE | 2018 |
|
RU2701733C1 |
| METHOD FOR SPECIFIC PROPHYLAXIS OF INFECTIOUS EPIDIDYMITIS IN RAMS | 2004 |
|
RU2280470C2 |
